Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology
Open Access
- 19 September 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (18) , 10063
Abstract
Renovascular hypertension (RH), a secondary hypertension, can significantly impact heart health, resulting in heart damage and dysfunction, thereby elevating the risk of cardiovascular diseases. Coniferol (CA), which has vascular relaxation properties, is expected to be able to treat hypertension-related diseases. However, its potential effects on cardiac function after RH remain unclear. In this study, in combination with network pharmacology, the antihypertensive and cardioprotective effects of CA in a two-kidney, one-clip (2K1C) mice model and its ability to mitigate angiotensin II (Ang II)-induced hypertrophy in H9C2 cells were investigated. The findings revealed that CA effectively reduced blood pressure, myocardial tissue damage, and inflammation after RH. The possible targets of CA for RH treatment were screened by network pharmacology. The interleukin-17 (IL-17) and tumor necrosis factor (TNF) signaling pathways were identified using a Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The inflammatory response was identified using a Gene Ontology (GO) enrichment analysis. Western blot analysis confirmed that CA reduced the expression of IL-17, matrix metallopeptidase 9 (MMP9), cyclooxygenase 2 (COX2), and TNF α in heart tissues and the H9C2 cells. In summary, CA inhibited cardiac inflammation and fibrohypertrophy following RH. This effect was closely linked to the expression of MMP9/COX2/TNF α/IL-17. This study sheds light on the therapeutic potential of CA for treating RH-induced myocardial hypertrophy and provides insights into its underlying mechanisms, positioning CA as a promising candidate for future drug development.Keywords
Funding Information
- Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sichuan University (HXYS19001, HXYS19002, ZYXY21002, 161200012)
- 135 project for disciplines of excellence, West China Hospital, Sichuan University (HXYS19001, HXYS19002, ZYXY21002, 161200012)
- Innovative Chinese Medicine Preclinical Research Fund of “Liqing No.2”, West China Hospital, Sichuan University (HXYS19001, HXYS19002, ZYXY21002, 161200012)
This publication has 48 references indexed in Scilit:
- Integrated transcriptomics and metabolomics reveal protective effects on heart of hibernating Daurian ground squirrelsJournal of Cellular Physiology, 2023
- Study on the mechanism of stir-fried Fructus Tribuli in enhancing the essential hypertension treatment by an integrated "spectrum-effect relationship-network pharmacology-metabolomics" strategyBiomedicine & Pharmacotherapy, 2023
- AIFM1, negatively regulated by miR-145-5p, aggravates hypoxia-induced cardiomyocyte injuryBiomedical Journal, 2022
- Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive ratsBiomedicine & Pharmacotherapy, 2022
- Renal Revascularization Attenuates Myocardial Mitochondrial Damage and Improves Diastolic Function in Pigs with Metabolic Syndrome and Renovascular HypertensionJournal of Cardiovascular Translational Research, 2021
- Lagenaria siceraria and it's bioactive constituents in carbonic anhydrase inhibition: A bioactivity guided LC–MS/MS approachPhytochemical Analysis, 2020
- Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular diseaseBasic Research in Cardiology, 2020
- Improving bioconversion of eugenol to coniferyl alcohol by in situ eliminating harmful H2O2Bioresource Technology, 2018
- Augmentation of ferulic acid-induced vasorelaxation with aging and its structure importance in thoracic aorta of spontaneously hypertensive ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2015
- Comparison of Benazepril Plus Amlodipine or Hydrochlorothiazide in High-Risk Patients With Hypertension and Coronary Artery DiseaseThe American Journal of Cardiology, 2013